Page last updated: 2024-10-25

clofibric acid and Syndrome

clofibric acid has been researched along with Syndrome in 1 studies

Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.

Syndrome: A characteristic symptom complex.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leaf, DA1

Reviews

1 review available for clofibric acid and Syndrome

ArticleYear
Chylomicronemia and the chylomicronemia syndrome: a practical approach to management.
    The American journal of medicine, 2008, Volume: 121, Issue:1

    Topics: Chylomicrons; Clofibric Acid; Diagnosis, Differential; Fatty Acids, Omega-3; Humans; Hypertriglyceri

2008